Medical News Today: Cholesterol News

Cholesterol News From Medical News Today Thu, 02 Sep 2010 18:54:33 +0200 Data From Mipomersen Phase 3 Trial In heFH Patients Presented At ESC Genzyme Corp. (NASDAQ: GENZ) and Isis Pharmaceuticals Inc. (NASDAQ: ISIS) announced that data from the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) were presented at the European Society of Cardiology's Congress 2010 in Stockholm, Sweden... Wed, 01 Sep 2010 06:00:00 PDT Netherlands Study Shows Need For Dose Management Care When Switching To Generic Statins Research conducted in the Netherlands has highlighted the need for care when switching patients under treatment for high cholesterol from branded to generic drug families. The study shows that much of the switching can result in patients inadvertently receiving non-equivalent doses, potentially leading to an increased risk of downstream heart disease and stroke... Wed, 01 Sep 2010 00:00:00 PDT Grapefruit's Bitter Taste Holds A Sweet Promise For Diabetes Therapy Naringenin, an antioxidant derived from the bitter flavor of grapefruits and other citrus fruits, may cause the liver to break down fat while increasing insulin sensitivity, a process that naturally occurs during long periods of fasting... Fri, 27 Aug 2010 01:00:00 PDT Expanded Lipoprotein Testing, VAP® Cholesterol Test Discussed At National Lipid Association Summer Clinical Lipid Update Atherotech Diagnostics Lab will exhibit its VAP® Cholesterol Test in booth 105 at the National Lipid Association (NLA) Summer 2010 Clinical Lipid Update. The meeting takes place August 27-29 at the Mayflower Hotel in Washington, D.C... Thu, 26 Aug 2010 03:00:00 PDT Impax Laboratories Confirms Patent Challenge Relating To VYTORIN(R), 10 Mg/80 Mg Impax Laboratories, Inc. (NASDAQ: IPXL) today confirms that it has initiated a challenge of patents listed by MSP Singapore Co. LLC in connection with VYTORIN® (ezetimibe/simvastatin), 10 mg/80 mg. Impax filed its Abbreviated New Drug Application ("ANDA") containing a paragraph IV certification for a generic version of VYTORIN® with the U.S. Food & Drug Administration ("FDA")... Mon, 23 Aug 2010 03:00:00 PDT Outlets Should Offer Free Statins With Junk Food Say UK Researchers Imagine this: order a cheeseburger and fries, and pick up a free cholesterol-busting statin tablet along with the other free condiments, that's what a group of UK researchers suggests you should be able to do at fast food outlets as a way to offset the increase in heart attack risk from eating junk food... Fri, 13 Aug 2010 02:00:00 PDT Amarin's AMR101 Pivotal Phase 3 MARINE Clinical Trial Completes Patient Enrollment And Randomization Amarin Corporation plc (Nasdaq: AMRN), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, announced that its MARINE trial, a Phase 3 clinical trial of AMR101, has completed patient enrollment and randomization into the treatment phase of this trial... Wed, 11 Aug 2010 02:00:00 PDT Abbott's SIMCOR® (Niacin Extended-Release / Simvastatin) Receives FDA Approval For New Dosage Strengths Abbott has received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of SIMCOR®, a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simvastatin - the most commonly prescribed dose of simvastatin - with either 500 mg or 1,000 mg of niacin extended-release... Fri, 06 Aug 2010 03:00:00 PDT Disrupting Body Clock Could Keep Triglycerides High, Raising Risk Of Heart Disease From studies on mice, researchers in the US have discovered that disrupting the body clock or circadian rhythm could interfere with a normal 24 hour cycle of high and low triglycerides in a way that leaves them at a high level all the time, potentially raising the risk of atherosclerosis and heart disease. You can read how Dr M... Thu, 05 Aug 2010 08:00:00 PDT 95 Genetic Variants Associated With Cholesterol, Triglycerides, Identified By Scientists A global team of researchers co-led by the University of Michigan School of Public Health has discovered or confirmed 95 regions of the human genome where genetic variants are associated with blood cholesterol and triglyceride levels, which are major indicators of heart disease risk... Thu, 05 Aug 2010 04:00:00 PDT